These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8027563)
1. Specific stimulation of Graves' disease thyrocytes by the natural anti-Gal antibody from normal and autologous serum. Winand RJ; Devigne JW; Meurisse M; Galili U J Immunol; 1994 Aug; 153(3):1386-95. PubMed ID: 8027563 [TBL] [Abstract][Full Text] [Related]
2. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells. Winand RJ; Anaraki F; Etienne-Decerf J; Galili U J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224 [TBL] [Abstract][Full Text] [Related]
4. The alpha-galactosyl epitope on human normal and autoimmune thyroid cells. Thall A; Etienne-Decerf J; Winand RJ; Galili U Autoimmunity; 1991; 10(2):81-7. PubMed ID: 1723633 [TBL] [Abstract][Full Text] [Related]
5. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect? Sospedra M; Obiols G; Babi LF; Tolosa E; Vargas F; Roura-Mir C; Lucas-Martin A; Ercilla G; Pujol-Borrell R J Immunol; 1995 Apr; 154(8):4213-22. PubMed ID: 7706756 [TBL] [Abstract][Full Text] [Related]
6. Application of mouse monoclonal antibodies for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometry. Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Dadan J Autoimmunity; 2005 Dec; 38(8):605-11. PubMed ID: 16390813 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose. LaTemple DC; Henion TR; Anaraki F; Galili U Cancer Res; 1996 Jul; 56(13):3069-74. PubMed ID: 8674064 [TBL] [Abstract][Full Text] [Related]
8. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen. Baker JR; Saunders NB; Kaulfersch W; Burman KD J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790 [TBL] [Abstract][Full Text] [Related]
9. Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease. Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Ueki Y; Nakao H; Tezuka H; Matsunaga M; Fukuda T; Ishikawa N Clin Exp Immunol; 1988 Apr; 72(1):84-90. PubMed ID: 3260842 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice. Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581 [TBL] [Abstract][Full Text] [Related]
11. [Cytofluorymetric evaluation of antigen regions of human thyroid peroxidase in patients with Graves' disease and non-toxic multinodular goiter using mouse monoclonal antibodies]. Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Peter A; Dadan J Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(1):19-26. PubMed ID: 15850534 [TBL] [Abstract][Full Text] [Related]
12. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production. Iwatani Y; Iitaka M; Row VV; Volpé R Clin Invest Med; 1988 Aug; 11(4):279-85. PubMed ID: 3262474 [TBL] [Abstract][Full Text] [Related]
14. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody. Galili U Springer Semin Immunopathol; 1993; 15(2-3):155-71. PubMed ID: 7504839 [TBL] [Abstract][Full Text] [Related]
15. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay. Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678 [TBL] [Abstract][Full Text] [Related]
16. A possible role for the alpha 1-->3 galactosyl epitope and the natural anti-gal antibody in oncogenesis. Gollogly L; Castronovo V Neoplasma; 1996; 43(5):285-9. PubMed ID: 8996545 [TBL] [Abstract][Full Text] [Related]
17. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies. Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965 [TBL] [Abstract][Full Text] [Related]
18. Graves' Autoantibodies Exhibit Different Stimulating Activities in Cultures of Thyrocytes and Orbital Fibroblasts Not Reflected by Clinical Assays. Krieger CC; Kahaly GJ; Azam A; Klubo-Gwiezdzinska J; Neumann S; Gershengorn MC Thyroid; 2022 Jan; 32(1):90-96. PubMed ID: 34714162 [No Abstract] [Full Text] [Related]
19. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations. Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393 [TBL] [Abstract][Full Text] [Related]
20. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice. Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]